Are Inghams shares a buy, hold or sell after last week's crash?

Is it time to buy low?

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Inghams Group Ltd (ASX: ING) shares have been making headlines over the past week after investors heavily sold the poultry producers shares following earnings results. 

Let's quickly recap what happened. 

A woman looks quizzical while looking at a dollar sign in the air.

Image source: Getty Images

Share price tumbles on earnings results 

Inghams released interim FY26 results last Friday.

The company reported: 

  • Revenue of $1.61 billion for the 26 weeks to 27 December 2025, broadly flat year-on-year.
  • EBITDA fell 33.8% to $139.2 million.
  • Net profit after tax (NPAT) declined 64.9% to $18.1 million.
  • On an underlying pre-AASB 16 basis, EBITDA was $80.6 million, down 35% on the prior corresponding period.
  • Underlying NPAT (pre-AASB 16) fell 60.4% to $21.3 million.

Inghams reduced its FY26 underlying EBITDA pre AASB 16 guidance to $180 to $200 million, down from $215 to $230 million previously.

Investors were seemingly left disappointed by these results, as Inghams shares crashed 13% on Friday. 

Some investors saw an opportunity to buy-low yesterday, as the share price recovered a little over 2%. 

Inghams shares are now close to a 5-year low, and fresh guidance out of Morgans indicates it could be an attractive entry point. 

Here's what the broker had to say. 

Positive long term view 

In a note out of Morgans over the weekend, the broker said the 1H26 result was weak, but in line with guidance. 

It said as expected, gearing was above the Board's target range and FY26 guidance was revised by 13-16%. 

Importantly, ING has now dealt with its excess inventory levels, core poultry volumes are back in growth, selling prices are higher than the pcp and normal production settings and improved network efficiency should result in a much stronger 2H26 vs 1H26.

The broker said the annualised benefit from these more normalised operating conditions should eventuate in FY27, resulting in a strong earnings recovery. 

After the severe share price weakness, we upgrade to a BUY rating.

What are other experts saying about Inghams shares?

Inghams shares closed trading yesterday at $2.16. 

It is down more than 14% year to date and roughly 37% over the last 12 months. 

While upside may be limited, analysts see the current price as undervalued. 

The average rating of 7 analysts via TradingView places a 1 year price target of $2.38 on Inghams shares. 

That indicates an upside of 10.38% from current levels. 

However, Inghams also just announced an interim dividend of 4 cents per share, which would translate to 3.75% yield over the year should it repeat. 

Including this yield in 12 month projections, this could push the total upside over 14%. 

Motley Fool contributor Aaron Bell has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

A woman smiles at the outlook she sees through binoculars.
Broker Notes

Buy, hold, sell: Newmont, Stockland, NAB shares

Let's check out some new expert recommendations.

Read more »

Red sell button on an Apple keyboard.
Broker Notes

Sell alert! Why this expert is calling time on Whitehaven and Beach Energy shares

A leading analyst forecasts mounting headwinds for Whitehaven and Beach Energy shares. But why?

Read more »

A group of stockbrokers sit in a room with several computer screens in front of them as they discuss the Zip share price and Zip's merger with Sezzle
Broker Notes

Buy, hold, sell: WiseTech, Whitehaven, AMP shares

Let's start the week with some fresh ratings from the experts. 

Read more »

A woman leans forward with her hand behind her ear, as if trying to hear information.
Broker Notes

How high does Macquarie think Resmed shares will go?

The hearing device company looks undervalued, according to the Macquarie team.

Read more »

Woman sitting on a chair by the pool on her laptop, looking at a stock market chart.
Broker Notes

Guess which ASX stock could rise 35%

Bell Potter has good things to say about this exciting stock.

Read more »

Smiling Indian manager leaning on chair.
Broker Notes

Experts name 3 ASX shares to buy this week

Let's see which shares are being recommended this week.

Read more »

Broker written in white with a man drawing a yellow underline.
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

A white EV car and an electric vehicle pump with green highlighted swirls representing ASX lithium shares
Broker Notes

Here's what brokers tip for PLS shares over the next 12 months

PLS shares ripped 275% in FY26. Here are 6 new 12-month share price targets from the experts.

Read more »